Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations [3] (multiple letters)

Journal of the American Medical Association

Volumn 283, Issue 23, 2000, Pages 3070-3072

  Miller, Lesley Ann ^a   Singer, Mendel E ^a   Swanson, Gregory P ^b   Schrag, Deborah ^c   Kuntz, Karen M ^d   Garber, Judy E ^e   Weeks, Jane C ^e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Memorial Sloan Kettering Cancer Center ^*  (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; BRCA1 PROTEIN;

BREAST TUMOR; FEMALE; GENETICS; HUMAN; MASTECTOMY; NOTE; TUMOR SUPPRESSOR GENE; BREAST CANCER; CANCER MORTALITY; GENE MUTATION; LETTER; PENETRANCE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE;

BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; HUMANS; MASTECTOMY; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS;

EID: 0034697566     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.23.3070     Document Type: Letter

References (0)